Therefore, once a diagnosis of OD with IDH R132H mutation is made, we consider it be useful to perform close surveillance through brain contrast-enhanced MRI, to detect possible early stage gliomas, when still asymptomatic, of small size, without compromission of the neurological functional areas nor vital neurovascular structures, so to plan the best tailored management. The gene discussed is IDH2; the disease is central nervous system cancer.